Related Experiment Video
Updated: Aug 7, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
[Cardiovascular abnormalities in systemic lupus erythematosus patients in echocardiographic assessment]
Lidia Ostanek1, Edyta Płońska, Małgorzata Peregud-Pogorzelska
1Pomorska Akademia Medyczna w Szczecinie, Klinika Reumatologii. lidia-55@go2.pl
Insights
Cardiac involvement is common in systemic lupus erythematosus (SLE), often affecting the pericardium and valves early. Antiphospholipid antibodies are key risk factors for these cardiovascular complications in SLE patients.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Cardiovascular disease is a leading cause of mortality in Systemic Lupus Erythematosus (SLE).
- Understanding cardiac involvement and its risk factors in SLE is crucial for patient management.
Purpose of the Study:
- To assess cardiac involvement in SLE patients.
- To identify clinical, serological, and environmental risk factors associated with cardiac complications in SLE.
Main Methods:
- 103 SLE patients and 25 controls underwent physical examination and echocardiography.
- Serological tests included ANA, ENA, antiphospholipid antibodies, ANCA, and AECA.
- Echocardiographic assessment focused on pericardial, valvular, and myocardial abnormalities.
Main Results:
- SLE patients showed higher rates of pericardial (58%), mitral valve (54%), and aortic valve (36%) abnormalities.
- Cardiac pathologies correlated with antiphospholipid antibodies, ANCA, anti-histone, and AECA.
- High SLE activity and shorter disease duration were linked to increased cardiovascular manifestations like pericarditis.
Conclusions:
- Cardiac involvement, particularly pericardial and valvular issues, is a frequent early complication of SLE.
- Serological factors, especially antiphospholipid antibodies, play a significant role in SLE cardiovascular pathogenesis.
- Pericarditis indicates high SLE activity and warrants close cardiovascular monitoring.
Unlabelled:
Cardiovascular system involvement is the third most common reason of death in patients with systemic lupus erythematosus (SLE). The aim of this study was to assess the cardiac involvement in the SLE patients with a regard to clinical, serological and environmental risk factors.
Material And Methods:
103 patients were included into the study, 91 women and 12 men, aged 16-74 yrs, the control group included 25 subjects. Physical examination, two-dimensional guided M-mode and Doppler echocardiographic recordings were performed. The tests for the presence of ANA, ENA, antiphospholipid antibodies (aCL, LA, anti-beta2GPI and antiprothrombin antibodies), ANCA (anti-neutrophil cytoplasm antibodies), AECA (anti endothelial cell antibodies) were carried out.
Results:
The following pathologies were significantly more common in the SLE patients: pericardial involvement (58%), organic changes of the mitral valve cusps (54%), organic changes of the aortic valve cusps (36%), widening of the aortal lumen (35%), enlargement of the left atrium (18%), hypokinesis of the left ventricle myocardial muscle (15%). Ultrasound cardiac pathologies were associated with presence of antiphospholipid antibodies, ANCA, anti-hitone antibodies and AECA. High activity of SLE increased risk of pericarditis and ascending aortic wall thickening. Cardiovascular manifestations occurred most frequently in patients with short time duration of SLE.
Conclusion:
Cardiac involvement is a frequent and early systemic complication of SLE and it is the most commonly related to pericardium and valvular apparatus. Cardiovascular manifestations in SLE patients are the most frequently related to the presence of serological risk factors, mainly antiphospholipid antibodies. It suggests their major role in the pathogenesis of the cardiovascular involvement in SLE. Pericarditis are markers of high activity of SLE.
Related Concept Videos
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops:
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
